Trial Profile
Effect of raltegravir-based antiretroviral therapy (ART) on treatment response among ART-naive patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Nov 2017
Price :
$35
*
At a glance
- Drugs Efavirenz (Primary) ; Raltegravir (Primary)
- Indications HIV-2 infections
- Focus Therapeutic Use
- 16 Nov 2017 New trial record
- 02 Nov 2017 Results published in the AIDS